Despite the resolution of macular edema and restoration of anatomical morphology, the majority of patients (72.7%) did not seek further medical attention due to the lack of improvement in their vision, which could be attributed to the reduced contrast sensitivity and stereo vision in the affected eye following anti-VEGF treatment[23, 24]. The gene discussed is VEGFA; the disease is macular retinal edema.